Anti-dementia drug use among individuals without a documented dementia diagnosis
Background: Anti-dementia agents are only indicated for mild to moderate dementia without any other approved uses. Thus, individuals taking these agents should have a documented diagnosis of dementia. A documented diagnosis can influence the level of care; however, many dementia patients remain undiagnosed. (Source: Research in Social and Administrative Pharmacy)
Source: Research in Social and Administrative Pharmacy - May 1, 2018 Category: Pharmaceuticals Authors: Teyrra Crawford, Maya Hanna, Eleanor Perfetto Source Type: research

Impact of the HITECH Act's incentive program on the adoption of drug-drug interaction alerts and electronic prescribing in the ambulatory care setting
Background: The 2009 Health Information Technology for Economic and Clinical Health (HITECH) Act has allocated billions of dollars as incentives through the meaningful use (MU) program to promote the implementation of electronic health record (EHR) systems nationwide. The use of drug-drug interaction (DDI) alerts, electronic prescribing (eRx), and computerized physician order entry (CPOE) systems integrated into EHR systems has now become mandatory for providers to achieve MU compliance and qualify for financial incentives, that ultimately aimed to reduce medication errors, and improve patient outcomes and adherence. (Sour...
Source: Research in Social and Administrative Pharmacy - May 1, 2018 Category: Pharmaceuticals Authors: Mohammed Malhani, Mary Maneno, Earl Ettienne, La ’Marcus Wingate Source Type: research

Development of a self-assessment tool to measure fidelity to a pharmacy service to optimize medication use
Background: A consistent approach to delivery of pharmacy services is critical to achieve expected clinical outcomes and facilitate scale up. To ensure these services are being delivered as intended, implementation fidelity should be measured. (Source: Research in Social and Administrative Pharmacy)
Source: Research in Social and Administrative Pharmacy - May 1, 2018 Category: Pharmaceuticals Authors: Carrie Blanchard, Melanie Livet, Todd Sorensen, Mary Roth McClurg Source Type: research

Evaluation of quality of life after implementation of a clinical decision support tool for guiding chronic opioid therapy in a veteran population
Background: Opioid over-prescribing has created a national public health epidemic. The Veterans Health Administration ’s (VHA) paradigm shift in chronic non-cancer pain treatment started with the Opioid Safety Initiative in 2013. In 2014, The Veterans Integrated Service Network (VISN) 21 implemented a clinical decision support tool (CDST) for guiding chronic opioid therapy (COT). To assist clinicians in monitorin g pain intensity and interference with activity and enjoyment of life, the CDST utilizes the Pain average, Enjoyment of life, and General activity (PEG) assessment scale. (Source: Research in Social and Administrative Pharmacy)
Source: Research in Social and Administrative Pharmacy - May 1, 2018 Category: Pharmaceuticals Authors: Aaron Leyba, Jennifer Marin, Diana Higgins, Scott Mambourg Source Type: research

Impact of a retrospective drug utilization review program on changing opioid prescribing behavior
Background: The opioid epidemic has reached unprecedented heights, and as federal drug policy efforts have focused on improving opioid prescribing, so have managed care organizations become increasingly concerned about developing strategies to impact prescribing behavior. To this end, Humana, a large, national health plan, launched its High Dose Prescriber Program in 2016 to communicate with its highest volume opioid prescribers and ensure the safe prescribing of opioid medications. The program was a retrospective drug utilization review mailing campaign that included a customized DUR scorecard which detailed the opioid pr...
Source: Research in Social and Administrative Pharmacy - May 1, 2018 Category: Pharmaceuticals Authors: Jonathan Chiang, Phil Schwab, Ryan McCulloch, Phyllis Brooks, Clay Rhodes, Laura Happe Source Type: research

Data as an effective tool to boost medication adherence
Background: Medication adherence remains an obstacle to saving lives, controlling costs and improving the quality of healthcare. Statistics show that nearly three of five American adults take at least one daily medication and separate data indicate that from 2000 to 2012, the proportion of people taking five or more prescription medications had doubled. A recent report estimated 20-50% of patients are noncompliant with drug therapy. Additionally, poor medication adherence following hospitalization costs the U.S. (Source: Research in Social and Administrative Pharmacy)
Source: Research in Social and Administrative Pharmacy - May 1, 2018 Category: Pharmaceuticals Authors: Bobbie Riley, Anton Berisha, Brian Eidex Source Type: research

Evaluating factors affecting provider acceptance rate of pharmacist-recommended interventions for HIV-infected patients
Background: Medication therapy management (MTM) and patient clinical assessments performed by the AIDS Healthcare Foundation (AHF) Integrated Medication Management (IMM) pharmacists aim to clinically assess patients for medication appropriateness, drug interactions, and proper medication administration and allow AHF pharmacists to make clinical interventions based on identified medication-related problems. (Source: Research in Social and Administrative Pharmacy)
Source: Research in Social and Administrative Pharmacy - May 1, 2018 Category: Pharmaceuticals Authors: Maryanna Golovash, Slava Starobinets, Maisie Nguyen, Victor Kao Source Type: research

Creating oncology content experts to support the development and growth for a PGY2 Oncology Residency Program
Background: In 2013, we sought to launch a PGY2 Oncology Residency Program. However, we had only 1 preceptor who was credentialed to precept this resident. This was largely due a lack of experienced, clinically oriented as well as board certified, residency trained pharmacists. (Source: Research in Social and Administrative Pharmacy)
Source: Research in Social and Administrative Pharmacy - May 1, 2018 Category: Pharmaceuticals Authors: Jeffrey Reichard, Heather Nelkin, Amanda Edwards, Matthew Jay Brown Source Type: research

Can lowering generics member cost share impact CMS star adherence metrics?
Background: The Stars formulary benefit program (SFB) was implemented throughout 2016 to increase adherence in Medicare Advantage populations by lowering the member cost of Star adherence generic drugs to $0 to $2 per 30-day supply. (Source: Research in Social and Administrative Pharmacy)
Source: Research in Social and Administrative Pharmacy - May 1, 2018 Category: Pharmaceuticals Authors: Steven Champaloux, Patrick Gleason Source Type: research

Impact of the 2016 Missed Refill intervention on medication refill rate and 2016 CMS star adherence for medicare populations
Background: The 2016 Missed Refill program (MR) was a Medicare member outreach program intended to increase adherence among CMS Star drug categories (cholesterol, diabetes, and hypertension) by encouraging members to refill their medication. (Source: Research in Social and Administrative Pharmacy)
Source: Research in Social and Administrative Pharmacy - May 1, 2018 Category: Pharmaceuticals Authors: Steven Champaloux, Patrick Gleason Source Type: research

Comparative effectiveness of MTM eligibility criteria under ACA and MMA across racial and ethnic groups in medicare
Background: Medicare medication therapy management (MTM) services were implemented in accordance with Medicare Modernization Act (MMA) and have been shown to significantly improve pharmacotherapy outcomes. (Source: Research in Social and Administrative Pharmacy)
Source: Research in Social and Administrative Pharmacy - May 1, 2018 Category: Pharmaceuticals Authors: Junling Wang, Yanru Qiao, Christina Spivey, Ya-Chen Tina Shih, Jim Wan, Julie Kuhle, Samuel Dagogo-Jack, William C. Cushman, Marie Chisholm-Burns Source Type: research

To evaluate the impact on the Medicare Stars medication adherence rates through the implementation of a pharmacy technician outreach program at a health plan
Background: The Medicare Star rating program measures how well plans perform based on a list of quality metrics including clinical, pharmacy, member satisfaction with their plan, health outcomes, and plan operations. Healthfirst is currently a 3.5 Star plan and in an effort to improve that rating, the pharmacy department was tasked to improve the triple weighted Patient Safety measures; Adherence to oral diabetes, RAS agents and statin medications. (Source: Research in Social and Administrative Pharmacy)
Source: Research in Social and Administrative Pharmacy - May 1, 2018 Category: Pharmaceuticals Authors: Alexandra Cruz, Helen Kourlas, Jason Barretto, Suhayr Islam, Malika Phillips-Peters, Bhavesh Modi Source Type: research

Impact of a pharmacy-led medication adherence program for disease-modifying therapies (DMTs) in patients with Multiple Sclerosis (MS)
Background: Adherence to DMTs in the treatment of MS has shown to improve clinical outcomes by reducing the likelihood of relapse and the number of hospitalizations and emergency room visits, but it is often difficult to achieve and even more challenging to sustain for many patients. PerformRx ℠ is a pharmacy benefit manager dedicated to innovation and providing the most efficacious outcomes. The Clinical Outcomes and Therapeutic Optimization Department carries out a variety of drug therapy management programs tailored to the needs of the patients and providers, including medication adh erence programs for high-cost, hig...
Source: Research in Social and Administrative Pharmacy - May 1, 2018 Category: Pharmaceuticals Authors: Courtney Spina, Mariel Shull, Sheena Cherian Source Type: research

Expansion of an Integrated Delivery Network (IDN) specialty pharmacy through targeted clinic engagement and focused administrative support
Background: As specialty medication utilization and associated costs grow, the specialty pharmacy has become ubiquitous in delivery of these medications. Limited payer contracting and antiquated pharmaceutical distribution practices divert IDN based specialty pharmacy volume to for-profit companies which leads to compromising local clinical care of IDN patients and increases total health care costs. (Source: Research in Social and Administrative Pharmacy)
Source: Research in Social and Administrative Pharmacy - May 1, 2018 Category: Pharmaceuticals Authors: Gregory Schardt, Kami Nolan Source Type: research

Use patterns of an electronic medication therapy management (MTM) platform in a nationwide mass merchant retail pharmacy setting
Background: Community pharmacies have several interactions with patients and are engaging in clinical services, such as medication therapy management (MTM). In March 2017, one nationwide mass merchant retail pharmacy implemented an electronic MTM platform to support Star Rating performance for health plans. Community pharmacists utilized the platform to address alerts (e.g. medication-related problems) and documented reasons if alerts were successful and unsuccessful. (Source: Research in Social and Administrative Pharmacy)
Source: Research in Social and Administrative Pharmacy - May 1, 2018 Category: Pharmaceuticals Authors: Patrick Campbell, Chanadda Chinthammit, Mike Warner, Kevin Boesen, Terri Warholak, Kevin Barton Source Type: research